Biotechblog – Page 1043 – Biotechnology business, policy, and more!

Want biotechnology venture capital? Use a shotgun!

On returning from a meeting with a small biotechnology firm in which I serve on the advisory board, I was […]

After months of work, the January issue of the Journal of Commercial Biotechnology, my first as managing editor, has just

My recent presentation at the “Biotechnology for Turkey” conference has been posted online. My central thesis was that the challenges

Guest content from John Avellanet, managing director of Cerulean Associates: The US Food and Drug Administration (FDA) intends to increase

At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so

I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University

Bio-Rad’s got an interesting website up: RethinkPCR. The company’s name isn’t posted on the front page, but is readily available

Today marks the 25th anniversary of the FDA’s approval of the first drug produced by biotechnology, Genentech’s Humulin. I often

I’ve been waiting to write up the Exubera story for the next edition of Building Biotechnology, and the story just

I’ll be speaking at the Biotech for Turkey conference in Istanbul on November 7th. This conference, convened by Bosfor Biotech